The company's orthopedic sales declined -49% in 2Q20 but recovered significantly from -80% declines in April. Integra expects improvement through 2H20.
The company's sales improved throughout 2Q20 but exited June with declines in the mid-teens. Orthofix remains cautious about second-half unpredictability.
The company's sales accelerated through 2Q20 and grew in the high single digits in July, but it cautioned that the new patient pipeline could slow in 2H20.
The company exited 2Q20 with double-digit growth that accelerated to the mid-teens in July as new products and competitive rep hiring drove share gains.